Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML
Elspeth Payne(University College London Hospitals NHS Foundation Trust), A. Thomas Look(Dana-Farber Cancer Institute), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Arati Khanna‐Gupta(Cellworks Research (India)), Niccolò Bolli(University of Milan), Alan H. Beggs(Boston Children's Hospital), Richard M. Stone(Dana-Farber Cancer Institute), Cyrus V. Hedvat(Memorial Sloan Kettering Cancer Center), Hong Sun(Unknown), Jennifer Rhodes(Brigham and Women's Hospital), Hanna T. Gazda(Boston Children's Hospital), John P. Kanki(Dana-Farber Cancer Institute), Finbarr E. Cotter(Queen Mary University of London), Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center)
Cited by 52
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k